IMMP Immutep Limited
$3.15▲ +1.61%
Healthcare
Other
Volume 13.6K
Avg Volume (10D) 17.1K
Key Metrics & Fundamentals
Market Cap
$23.21M
P/E Ratio
–
Div Yield
0.00%
52W Range
3.05 - 70.60
% vs 50 MA
59.72%
% vs 200 MA
115.33%
RSI-14
52.3
MACD Histogram
-0.1500
Beta (1Y vs SPY)
-8.00
Free Cash Flow
-$40.43M
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Loading chart…
Recent News
Immutep Announces Presentation of Quality of Life Data from EFTISARC-NEO Phase II Trial at ESMO 2026
GlobeNewswire · Oct 23, 2026 8:00 AM ET
Immutep Announces Late-Breaking Abstract on IMP761 Accepted for Poster Presentation at ACR Convergence 2026
GlobeNewswire · Oct 19, 2026 8:00 AM ET
Immutep and Monash University Secure Further ARC Linkage Projects Funding for LAG-3 Research
GlobeNewswire · Oct 14, 2026 8:00 AM ET
Immutep Regains Compliance with Nasdaq Minimum Bid Price Requirement
GlobeNewswire · Oct 13, 2026 8:00 AM ET
Immutep Receives ~A$0.86 Million R&D Tax Incentive
GlobeNewswire · Sep 30, 2026 8:00 AM ET
Change to American Depositary Share Ratio
GlobeNewswire · Sep 21, 2026 8:00 AM ET
Immutep Outlines Focused Development Strategy for Eftilagimod Alfa (“efti”)
GlobeNewswire · Sep 11, 2026 8:00 AM ET
Immutep Quarterly Activities Report Q4 FY26
GlobeNewswire · Jul 30, 2026 8:00 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See IMMP's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.